Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Russell, Beth"'
Autor:
Russell B; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Science, King's College London, London, UK. Beth.russell@kcl.ac.uk., Hadi H; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Science, King's College London, London, UK., Moss CL; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Science, King's College London, London, UK., Green S; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Science, King's College London, London, UK., Haire A; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Science, King's College London, London, UK., Wylie H; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Science, King's College London, London, UK., Handford J; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Science, King's College London, London, UK., Monroy-Iglesias M; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Science, King's College London, London, UK., Dickinson H; South-East London Cancer Alliance, London, UK., Haire K; South-East London Cancer Alliance, London, UK., Van Hemelrijck M; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Science, King's College London, London, UK.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 May 01; Vol. 32 (5), pp. 321. Date of Electronic Publication: 2024 May 01.
Autor:
Russell B; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Moss C; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. charlotte.moss@kcl.ac.uk., Monroy-Iglesias M; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Roberts G; South East London Cancer Alliance, London, UK., Dickinson H; South East London Cancer Alliance, London, UK., Haire K; South East London Cancer Alliance, London, UK., Innes K; Cancer Informatics and Data, Guy's and St. Thomas NHS Foundation Trust, London, UK., Mulji-Shah B; Cancer Informatics and Data, Guy's and St. Thomas NHS Foundation Trust, London, UK., Castell F; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK., Al-Salihi O; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK., Lei M; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK., Francis A; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK., Dann B; Cancer Informatics and Data, Guy's and St. Thomas NHS Foundation Trust, London, UK., Jogia V; Cancer Informatics and Data, Guy's and St. Thomas NHS Foundation Trust, London, UK., Hamid H; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK., Challacombe B; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK., Simo R; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK., Fraser S; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK., Gousis C; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK., Sawyer E; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK., Tsotra E; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK., Roca J; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK., Khan M; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK., Josephs D; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK., Enting D; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK., Van Hemelrijck M; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Harris V; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK., Dolly S; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK.
Publikováno v:
British journal of cancer [Br J Cancer] 2022 Oct; Vol. 127 (7), pp. 1289-1295. Date of Electronic Publication: 2022 Jul 15.
Autor:
Monroy-Iglesias MJ; King's College London, School of Cancer & Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, SE1 9RT, UK., Tremble K; Medical Oncology, Guy's & St. Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK., Russell B; King's College London, School of Cancer & Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, SE1 9RT, UK., Moss C; King's College London, School of Cancer & Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, SE1 9RT, UK., Dolly S; Medical Oncology, Guy's & St. Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK., Sita-Lumsden A; Medical Oncology, Guy's & St. Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK., Cortellini A; Division of Cancer, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, W120HS, UK., Pinato DJ; Division of Cancer, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, W120HS, UK.; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Rigg A; Medical Oncology, Guy's & St. Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK., Karagiannis SN; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, London, SE1 9RT, UK., Van Hemelrijck M; King's College London, School of Cancer & Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, SE1 9RT, UK.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2022 Oct; Vol. 18 (32), pp. 3585-3594. Date of Electronic Publication: 2022 Sep 29.
Autor:
Hadi H; Translational Oncology & Urology Research (TOUR), School of Cancer & Pharmaceutical Sciences, King's College London, London, SE1 9RT, UK., Handford J; Translational Oncology & Urology Research (TOUR), School of Cancer & Pharmaceutical Sciences, King's College London, London, SE1 9RT, UK., Russell B; Translational Oncology & Urology Research (TOUR), School of Cancer & Pharmaceutical Sciences, King's College London, London, SE1 9RT, UK., Moss CL; Translational Oncology & Urology Research (TOUR), School of Cancer & Pharmaceutical Sciences, King's College London, London, SE1 9RT, UK., Monroy Iglesias MJ; Translational Oncology & Urology Research (TOUR), School of Cancer & Pharmaceutical Sciences, King's College London, London, SE1 9RT, UK., Rammant E; Translational Oncology & Urology Research (TOUR), School of Cancer & Pharmaceutical Sciences, King's College London, London, SE1 9RT, UK., Smith S; Dimbleby Cancer Care, Guy's Cancer Centre, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK., Dolly S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK., Thillai K; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK., Rigg A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK., Hemelrijck MV; Translational Oncology & Urology Research (TOUR), School of Cancer & Pharmaceutical Sciences, King's College London, London, SE1 9RT, UK.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2022 Jun; Vol. 18 (18), pp. 2201-2216. Date of Electronic Publication: 2022 Apr 06.
Autor:
Tremble K; Guy's & St Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK.; Translational Oncology & Urology Research (TOUR), King's College London, London, SE1 9RT, UK., Fox L; Translational Oncology & Urology Research (TOUR), King's College London, London, SE1 9RT, UK., Moss C; Translational Oncology & Urology Research (TOUR), King's College London, London, SE1 9RT, UK., Russell B; Translational Oncology & Urology Research (TOUR), King's College London, London, SE1 9RT, UK., Aljazzaf H; Guy's & St Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK., Higgins F; Guy's & St Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK., Dann B; Guy's & St Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK., Jogia V; Guy's & St Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK., Roberts G; South East London Cancer Alliance, London, SE1 9RT, UK., Rigg A; Guy's & St Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK., Dolly S; Guy's & St Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK.; South East London Cancer Alliance, London, SE1 9RT, UK., Van Hemelrijck M; Translational Oncology & Urology Research (TOUR), King's College London, London, SE1 9RT, UK.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2022 Mar; Vol. 18 (10), pp. 1211-1218. Date of Electronic Publication: 2022 Jan 17.
Autor:
Pinato DJ; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom.; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Patel M; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom., Scotti L; Department of Translational Medicine, Unit of Medical Statistics, University of Piemonte Orientale, Novara, Italy., Colomba E; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Dolly S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Loizidou A; Department of Infectious Diseases, Internal Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Chester J; Medical Oncology, School of Medicine, Cardiff University, Cardiff, United Kingdom.; Medical Oncology, Velindre Cancer Centre, Cardiff, United Kingdom., Mukherjee U; Medical Oncology, Barts Health NHS Trust, London, United Kingdom., Zambelli A; Oncology Unit, Azienda Socio Sanitaria Territoriale, Papa Giovanni XXIII, Bergamo, Italy., Dalla Pria A; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom., Aguilar-Company J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain.; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Bower M; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom., Salazar R; Department of Medical Oncology, ICO L'Hospitalet, Oncobell Program, CIBERONC, Hospitalet de Llobregat, Spain., Bertuzzi A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Istituto di Ricovero e Cura a Carattere Scientifico, Humanitas Research Hospital, Rozzano, Milan, Italy., Brunet J; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Lambertini M; Medical Oncology Department, Istituto di Ricovero e Cura a Carattere Scientifico, Ospedale Policlinico San Martino, Genova, Italy.; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genova, Genova, Italy., Tagliamento M; Medical Oncology Department, Istituto di Ricovero e Cura a Carattere Scientifico, Ospedale Policlinico San Martino, Genova, Italy.; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genova, Genova, Italy., Pous A; Medical Oncology Department, Badalona Applied Research Group in Oncology, Institut Germans Trias i Pujol, Catalan Institute of Oncology-Badalona, Spain., Sita-Lumsden A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Srikandarajah K; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Colomba J; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Pommeret F; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Seguí E; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., Generali D; Multidisciplinary Breast Pathology and Translational Research Unit, Azienda Socio Sanitaria Territoriale, Cremona, Italy.; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy., Grisanti S; Medical Oncology Unit, Spedali Civili, Brescia, Italy., Pedrazzoli P; Medical Oncology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Humanitas Research Hospital, Policlinico San Matteo, Pavia, Italy.; Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy., Rizzo G; Medical Oncology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Humanitas Research Hospital, Policlinico San Matteo, Pavia, Italy., Libertini M; Medical Oncology Unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy., Moss C; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Evans JS; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom., Russell B; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Harbeck N; Department of Gynecology and Obstetrics, Breast Center and Gynecological Cancer Center and Comprehensive Cancer Center Munich, University Hospital Munich, Munich, Germany., Vincenzi B; Policlinico Universitario Campus Bio-Medico, Rome, Italy., Biello F; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Bertulli R; Medical Oncology 2, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Humanitas Research Hospital, Istituto Nazionale dei Tumori, Milan, Italy., Ottaviani D; Cancer Division, University College London Hospitals, London, United Kingdom., Liñan R; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Rossi S; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Istituto di Ricovero e Cura a Carattere Scientifico, Humanitas Research Hospital, Rozzano, Milan, Italy., Carmona-García MC; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Tondini C; Oncology Unit, Azienda Socio Sanitaria Territoriale, Papa Giovanni XXIII, Bergamo, Italy., Fox L; Department of Hematology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Baggi A; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy., Fotia V; Oncology Unit, Azienda Socio Sanitaria Territoriale, Papa Giovanni XXIII, Bergamo, Italy., Parisi A; Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila, Italy., Porzio G; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Queirolo P; Melanoma and Sarcoma Medical Treatment Unit, Istituto Europeo di Oncologia, Milan, Italy., Cruz CA; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., Saoudi-Gonzalez N; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Felip E; Medical Oncology Department, Badalona Applied Research Group in Oncology, Institut Germans Trias i Pujol, Catalan Institute of Oncology-Badalona, Spain., Roqué Lloveras A; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Newsom-Davis T; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom., Sharkey R; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom., Roldán E; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Reyes R; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., Zoratto F; Medical Oncology, St Maria Goretti Hospital, Latina, Italy., Earnshaw I; Cancer Division, University College London Hospitals, London, United Kingdom., Ferrante D; Department of Translational Medicine, Unit of Medical Statistics, University of Piemonte Orientale, Novara, Italy., Marco-Hernández J; Department of Internal Medicine, Hospital Clinic, Barcelona, Spain., Ruiz-Camps I; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Gaidano G; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore della Carità Hospital, Novara, Italy., Patriarca A; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore della Carità Hospital, Novara, Italy., Bruna R; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore della Carità Hospital, Novara, Italy., Sureda A; Haematology Department, Institut Catala d'Oncologia Hospitalet, Hospitalet de Llobregat, Bellvitge Institute for Biomedical Research, Universitat de Barcelona, Barcelona, Spain., Martinez-Vila C; Fundació Althaia Manresa, Manresa, Spain., Sanchez de Torre A; Hospital Universitario XII de Octubre Madrid, Spain., Berardi R; Medical Oncology, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Polytechnic University of the Marche Region, Ancona, Italy., Giusti R; Medical Oncology, St Andrea Hospital, Rome, Italy., Mazzoni F; Medical Oncology, Careggi University Hospital, Florence, Italy., Guida A; Department of Oncology, Azienda Ospedaliera Santa Maria, Terni, Italy., Rimassa L; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Istituto di Ricovero e Cura a Carattere Scientifico, Humanitas Research Hospital, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, Milan, Italy., Chiudinelli L; Oncology Unit, Azienda Socio Sanitaria Territoriale, Papa Giovanni XXIII, Bergamo, Italy., Franchi M; Oncology Unit, Azienda Socio Sanitaria Territoriale, Papa Giovanni XXIII, Bergamo, Italy., Krengli M; Division of Radiotherapy, Department of Translational Medicine, University of Piemonte Orientale and Azienda Ospedaliera Maggiore Della Carità, Novara, Italy., Santoro A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Istituto di Ricovero e Cura a Carattere Scientifico, Humanitas Research Hospital, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, Milan, Italy., Prat A; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain., Tabernero J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Baselga Oncological Institute at Quiron, Universitat de Vic - Universitat Central de Catalunya, Barcelona, Spain., Van Hemelrijck M; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Diamantis N; Medical Oncology, Barts Health NHS Trust, London, United Kingdom., Gennari A; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Cortellini A; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom.; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Publikováno v:
JAMA oncology [JAMA Oncol] 2022 Jan 01; Vol. 8 (1), pp. 114-122.
Autor:
Pinato DJ; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy. Electronic address: david.pinato@imperial.ac.uk., Tabernero J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Bower M; Department of Oncology, Chelsea and Westminster Hospital, London, UK; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Scotti L; Unit of Medical Statistics, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Patel M; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK., Colomba E; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Dolly S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Loizidou A; Department of Infectious Diseases, Internal Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Chester J; Medical Oncology, School of Medicine, Cardiff University, Cardiff, UK; Medical Oncology, Velindre Cancer Centre, Cardiff, UK., Mukherjee U; Medical Oncology, Barts Health NHS Trust, London, UK., Zambelli A; Oncology Unit, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Dalla Pria A; Department of Oncology, Chelsea and Westminster Hospital, London, UK; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Aguilar-Company J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Ottaviani D; Cancer Division, University College London Hospitals, London, UK., Chowdhury A; Cancer Division, University College London Hospitals, London, UK., Merry E; Cancer Division, University College London Hospitals, London, UK., Salazar R; Department of Medical Oncology, ICO L'Hospitalet, Oncobell Program, Hospitalet de Llobregat, Barcelona, Spain., Bertuzzi A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Brunet J; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Lambertini M; Medical Oncology Department, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genova, Genova, Italy., Tagliamento M; Medical Oncology Department, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genova, Genova, Italy., Pous A; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Sita-Lumsden A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Srikandarajah K; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Colomba J; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Pommeret F; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Seguí E; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., Generali D; Multidisciplinary Breast Pathology and Translational Research Unit, Azienda Socio Sanitaria Territoriale Cremona, Cremona, Italy; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy., Grisanti S; Medical Oncology Unit, Spedali Civili, Brescia, Italy; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Pedrazzoli P; Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy., Rizzo G; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Libertini M; Medical Oncology Unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy., Moss C; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Evans JS; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK., Russell B; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Harbeck N; Department of Gynecology and Obstetrics, Breast Center and Gynecological Cancer Center and Comprehensive Cancer Center Munich, University Hospital Munich, Munich, Germany., Vincenzi B; Policlinico Universitario Campus Bio-Medico, Rome, Italy., Biello F; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Azienda Ospedaliera Maggiore Della Caritá, Novara, Italy., Bertulli R; Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Liñan R; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Rossi S; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Carmona-García MC; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Tondini C; Oncology Unit, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Fox L; Haematology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Baggi A; Medical Oncology Unit, Spedali Civili, Brescia, Italy; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Fotia V; Oncology Unit, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Parisi A; Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila, Italy., Porzio G; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Saponara M; Melanoma and Sarcoma Medical Treatment Unit, Istituto Europeo di Oncologia, Milan, Italy., Cruz CA; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., García-Illescas D; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Felip E; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Roqué Lloveras A; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Sharkey R; Department of Oncology, Chelsea and Westminster Hospital, London, UK; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Roldán E; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Reyes R; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., Earnshaw I; Cancer Division, University College London Hospitals, London, UK., Ferrante D; Unit of Medical Statistics, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Marco-Hernández J; Department of Internal Medicine, Hospital Clinic, Barcelona, Spain., Ruiz-Camps I; Infectious Diseases, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Gaidano G; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Azienda Ospedaliera Maggiore Della Caritá, Novara, Italy., Patriarca A; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Azienda Ospedaliera Maggiore Della Caritá, Novara, Italy., Bruna R; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Azienda Ospedaliera Maggiore Della Caritá, Novara, Italy., Sureda A; Haematology Department, ICO L'Hospitalet, Oncobell Program, Hospitalet de Llobregat, Barcelona, Spain., Martinez-Vila C; Fundació Althaia Manresa, Manresa, Spain., Sanchez de Torre A; Hospital Universitario XII de Octubre, Madrid, Spain., Cantini L; Medical Oncology, Azienda Ospedaliero Universitaria, Ospedali Riuniti, Polytechnic University of the Marche Region, Ancona, Italy., Filetti M; Medical Oncology, Sant'Andrea Hospital, Rome, Italy., Rimassa L; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Chiudinelli L; Oncology Unit, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Franchi M; Oncology Unit, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Krengli M; Division of Radiotherapy, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Azienda Ospedaliera Maggiore Della Caritá, Novara, Italy., Santoro A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Prat A; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain, Barcelona, Spain., Van Hemelrijck M; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Diamantis N; Medical Oncology, Barts Health NHS Trust, London, UK., Newsom-Davis T; Department of Oncology, Chelsea and Westminster Hospital, London, UK; National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Gennari A; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Azienda Ospedaliera Maggiore Della Caritá, Novara, Italy., Cortellini A; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2021 Dec; Vol. 22 (12), pp. 1669-1680. Date of Electronic Publication: 2021 Nov 03.
Autor:
Chen M; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Raj R; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Fox L; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Moss CL; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., George G; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Karagiannis SN; St John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, London, UK.; Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Enting D; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Department of Medical Oncology, Guy's and Saint Thomas' NHS Foundation Trust, London, UK., Joseph M; Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK., Peat N; Guy's and St Thomas' NHS Foundation Trust, London, UK., Russell B; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK beth.russell@kcl.ac.uk., Van Hemelrijck M; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
Publikováno v:
BMJ open [BMJ Open] 2021 Oct 08; Vol. 11 (10), pp. e046052. Date of Electronic Publication: 2021 Oct 08.
Autor:
Russell B; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. beth.russell@kcl.ac.uk., Moss CL; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Shah V; Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Ko TK; Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Palmer K; King's College Hospital NHS Foundation Trust, London, UK., Sylva R; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., George G; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Monroy-Iglesias MJ; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Patten P; Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Ceesay MM; Department of Haematological Medicine, Princess Royal University Hospital, Farnborough, UK., Benjamin R; Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Potter V; Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Pagliuca A; Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Papa S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Irshad S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Ross P; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Spicer J; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Kordasti S; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Haematology Department, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Crawley D; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Wylie H; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Cahill F; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Haire A; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Zaki K; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Sita-Lumsden A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Josephs D; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Enting D; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Swampillai A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Sawyer E; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Clinical Oncology, Guy's and St Thomas NHS Foundation Trust (GSTT), London, UK., D'Souza A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Gomberg S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Harrison C; Haematology Department, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Fields P; Haematology Department, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Wrench D; Haematology Department, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Rigg A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Sullivan R; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Kulasekararaj A; Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Dolly S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Van Hemelrijck M; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK.
Publikováno v:
British journal of cancer [Br J Cancer] 2021 Sep; Vol. 125 (7), pp. 939-947. Date of Electronic Publication: 2021 Aug 16.
Autor:
Ward J; Department of Plastic Surgery, The Royal Marsden NHS Foundation Trust, London, UK., King I; Department of Plastic Surgery, The Royal Marsden NHS Foundation Trust, London, UK., Monroy-Iglesias M; Department of Translational Oncology and Urology Research, King's College London, London, UK., Russell B; Department of Translational Oncology and Urology Research, King's College London, London, UK., van Hemelrijck M; Department of Translational Oncology and Urology Research, King's College London, London, UK., Ramsey K; Department of Plastic Surgery, The Royal Marsden NHS Foundation Trust, London, UK., Khan AA; Department of Plastic Surgery, The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: aadil.khan@rmh.nhs.uk.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Jul; Vol. 151, pp. 233-244. Date of Electronic Publication: 2021 May 20.